Lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis

Lenalidomide is an IMiD drug which has been associated with a variety of potential immune related complications. We describe the case of a patient with newly diagnosed multiple myeloma along with a history of systemic mastocytosis who developed evidence of an autoimmune enteropathy shortly after ini...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakritz, Stephanie, Forsberg, Peter A., Sherbenou, Daniel W., Mark, Tomer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483819/
https://www.ncbi.nlm.nih.gov/pubmed/36188028
http://dx.doi.org/10.1002/ccr3.6199
_version_ 1784791751609810944
author Lakritz, Stephanie
Forsberg, Peter A.
Sherbenou, Daniel W.
Mark, Tomer M.
author_facet Lakritz, Stephanie
Forsberg, Peter A.
Sherbenou, Daniel W.
Mark, Tomer M.
author_sort Lakritz, Stephanie
collection PubMed
description Lenalidomide is an IMiD drug which has been associated with a variety of potential immune related complications. We describe the case of a patient with newly diagnosed multiple myeloma along with a history of systemic mastocytosis who developed evidence of an autoimmune enteropathy shortly after initiating lenalidomide based therapy.
format Online
Article
Text
id pubmed-9483819
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94838192022-09-29 Lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis Lakritz, Stephanie Forsberg, Peter A. Sherbenou, Daniel W. Mark, Tomer M. Clin Case Rep Case Report Lenalidomide is an IMiD drug which has been associated with a variety of potential immune related complications. We describe the case of a patient with newly diagnosed multiple myeloma along with a history of systemic mastocytosis who developed evidence of an autoimmune enteropathy shortly after initiating lenalidomide based therapy. John Wiley and Sons Inc. 2022-09-19 /pmc/articles/PMC9483819/ /pubmed/36188028 http://dx.doi.org/10.1002/ccr3.6199 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Lakritz, Stephanie
Forsberg, Peter A.
Sherbenou, Daniel W.
Mark, Tomer M.
Lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis
title Lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis
title_full Lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis
title_fullStr Lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis
title_full_unstemmed Lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis
title_short Lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis
title_sort lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483819/
https://www.ncbi.nlm.nih.gov/pubmed/36188028
http://dx.doi.org/10.1002/ccr3.6199
work_keys_str_mv AT lakritzstephanie lenalidomideinducedautoimmuneenteropathycomplicatingtreatmentofmultiplemyelomawithconcurrentsystemicmastocytosis
AT forsbergpetera lenalidomideinducedautoimmuneenteropathycomplicatingtreatmentofmultiplemyelomawithconcurrentsystemicmastocytosis
AT sherbenoudanielw lenalidomideinducedautoimmuneenteropathycomplicatingtreatmentofmultiplemyelomawithconcurrentsystemicmastocytosis
AT marktomerm lenalidomideinducedautoimmuneenteropathycomplicatingtreatmentofmultiplemyelomawithconcurrentsystemicmastocytosis

Ejemplares similares